It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ...

Pop star Lizzo admitted that she tried Ozempic and other trendy weight loss drugs after denying accusations that she used medications to shed weight. “It’s not easy,” Lizzo confessed during a ...

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s ...

A U.S. federal judge has upheld the FDA’s decision to remove semaglutide, the active ingredient in Ozempic and Wegovy, from ...

After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson’s over a decade ...

Dr Scales explained that Parkinson's and Alzheimer's share commonality – both are neurodegenerative diseases with overlapping ...

Dietitians are especially excited about one underrated nutrient: prebiotic chicory root fiber. Let’s break down what GLP-1 is ...

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.

GLP-1 medications such as Wegovy, Mounjaro and Ozempic helped drive a 9% year-over-year increase in U.S. prescription dispensing revenue, which reached $683 billion in 2024.  A separate report found ...

Fifty years of outstanding neuroscience research studies have revealed many secrets of how drugs of abuse affect and change ...

More than a dozen lawsuits filed in New York and New Jersey claim that weight-loss drugs like Wegovy and Ozempic caused ...